Philips recently announced two new capabilities of its echocardiogram system, the EPIQ CVx cardiology ultrasound platform, that will…
Articles by Vijaya Iyer, PhD
Owlstone Medical has established a strategic collaboration with Actelion Pharmaceuticals to develop and validate a breath-based diagnostic test for…
Teva Pharmaceutical Industries launched a generic version of Letairis (ambrisentan) in the United States for the treatment of…
Treatment with Revatio (sildenafil) after surgery to the heart’s mitral valve significantly lowered pulmonary arterial pressure in patients with…
An updated guideline with new recommendations for the treatment of patients with pulmonary arterial hypertension (PAH) was released by the…
Eligible pulmonary hypertension patients could gain access to financial assistance in paying for PH therapies approved by the U.S. Food and…
A ventilator-compatible nitric oxide generator and delivery system, called AirNOvent, for patients with pulmonary hypertension and related conditions, will…
The prevalence of pulmonary arterial hypertension (PAH) in South Korea is comparable with that reported in other countries, according…
The Stanford University School of Medicine is the first clinical site for a Phase 2 trial testing levosimendan…
Transgelin, a smooth muscle protein, is abundant in patients with irreversible pulmonary arterial hypertension (PAH)Â secondary to congenital heart…
Patients with mild pulmonary hypertension (PH), with a mean pulmonary arterial pressure between 19 and 21 mmHg, are at…
The Pulmonary Hypertension Association (PHA) will be using social media throughout this month to increase awareness about issues affecting patients…